Allegheny Health Network has signed an affiliation agreement with an independent Israeli organization that helps life science entrepreneurs bring new products to market.

The agreement between AHN’s Research Institute and the Israel Innovation Authority aims to bring an array of Israeli health care startups and other business development opportunities to Pittsburgh, providing a local research partner and base for American operations. AHN will provide facilities for pilot projects, advanced technology support and other program assistance.

“We’re excited to partner with the Israel Innovation Authority to help cultivate some of their country’s brightest health care startups and we’re thrilled to work with their entrepreneurs as they refine, test and scale innovative new technologies that may one day benefit patients and medical providers here in Pittsburgh and around the world,” Tariq J. Cheema, a physician and medical director of AHN Research Institute, said in a prepared statement.

Selected companies will receive up to 50% funding from the Israel Innovation Authority for conducting research and development projects with AHN.

Advertise with us

The collaboration with AHN is part of the authority’s International Health Centers R&D and Piloting program, which has partnered with the Mayo Clinic, Hartford HealthCare and Thomas Jefferson University Hospitals.

AHN is continuing to expand international business partnerships, recently inking deals with Splendo Health, Netherlands, and AdipoPharma, France, to share office and lab space and professional resources at the former AHN Suburban Hospital in Bellevue. The former community hospital is also home to AlphaLab Health, a life sciences business incubator operated by North Shore technology investor Innovation Works.

Kris B. Mamula: kmamula@post-gazette.com